ATE1858T1 - 15-methanesulfonamidoprostaglandin-derivate, ihre pharmazeutischen zusammensetzungen und verfahren dafuer. - Google Patents
15-methanesulfonamidoprostaglandin-derivate, ihre pharmazeutischen zusammensetzungen und verfahren dafuer.Info
- Publication number
- ATE1858T1 ATE1858T1 AT80303155T AT80303155T ATE1858T1 AT E1858 T1 ATE1858 T1 AT E1858T1 AT 80303155 T AT80303155 T AT 80303155T AT 80303155 T AT80303155 T AT 80303155T AT E1858 T1 ATE1858 T1 AT E1858T1
- Authority
- AT
- Austria
- Prior art keywords
- methanesulfonamidoprostaglandin
- derivatives
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/076,520 US4232173A (en) | 1979-09-17 | 1979-09-17 | 15-Sulfonamidoprostaglandin derivatives |
| EP80303155A EP0025687B1 (de) | 1979-09-17 | 1980-09-09 | 15-Methanesulfonamidoprostaglandin-Derivate, ihre pharmazeutischen Zusammensetzungen und Verfahren dafür |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE1858T1 true ATE1858T1 (de) | 1982-12-15 |
Family
ID=22132532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT80303155T ATE1858T1 (de) | 1979-09-17 | 1980-09-09 | 15-methanesulfonamidoprostaglandin-derivate, ihre pharmazeutischen zusammensetzungen und verfahren dafuer. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4232173A (de) |
| EP (1) | EP0025687B1 (de) |
| JP (1) | JPS5951938B2 (de) |
| KR (1) | KR840000964B1 (de) |
| AR (1) | AR225776A1 (de) |
| AT (1) | ATE1858T1 (de) |
| AU (1) | AU518068B2 (de) |
| CA (1) | CA1153368A (de) |
| DE (1) | DE3061160D1 (de) |
| DK (1) | DK392580A (de) |
| ES (1) | ES8106489A1 (de) |
| FI (1) | FI68615C (de) |
| GR (1) | GR70288B (de) |
| IE (1) | IE50266B1 (de) |
| IL (1) | IL61038A (de) |
| PH (1) | PH15098A (de) |
| PT (1) | PT71807B (de) |
| YU (1) | YU236180A (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61126069A (ja) * | 1984-11-21 | 1986-06-13 | Res Dev Corp Of Japan | プロスタグランジン誘導体 |
| JPS63207015A (ja) * | 1987-02-23 | 1988-08-26 | 株式会社日立製作所 | 遮断器装置 |
| JPS6429564A (en) * | 1987-07-25 | 1989-01-31 | Oyo Kikaku Kk | Common joist mechanism |
| US5387608A (en) * | 1993-08-17 | 1995-02-07 | Allergan, Inc. | Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents |
| US5607415A (en) * | 1994-08-18 | 1997-03-04 | Kimberly-Clark Corporation | Flexible absorbent article |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3835179A (en) * | 1972-07-24 | 1974-09-10 | American Cyanamid Co | Novel 15-substituted prostanoic acids and esters |
| US4033996A (en) * | 1973-04-25 | 1977-07-05 | Merck & Co., Inc. | 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins |
| GB1507211A (en) * | 1975-02-14 | 1978-04-12 | Ono Pharmaceutical Co | Prostaglandin analogues |
-
1979
- 1979-09-17 US US06/076,520 patent/US4232173A/en not_active Expired - Lifetime
-
1980
- 1980-09-09 EP EP80303155A patent/EP0025687B1/de not_active Expired
- 1980-09-09 AT AT80303155T patent/ATE1858T1/de not_active IP Right Cessation
- 1980-09-09 DE DE8080303155T patent/DE3061160D1/de not_active Expired
- 1980-09-15 CA CA000360249A patent/CA1153368A/en not_active Expired
- 1980-09-15 IE IE1927/80A patent/IE50266B1/en unknown
- 1980-09-15 YU YU02361/80A patent/YU236180A/xx unknown
- 1980-09-15 PT PT71807A patent/PT71807B/pt unknown
- 1980-09-15 IL IL61038A patent/IL61038A/xx unknown
- 1980-09-15 GR GR62889A patent/GR70288B/el unknown
- 1980-09-16 JP JP55128465A patent/JPS5951938B2/ja not_active Expired
- 1980-09-16 AU AU62436/80A patent/AU518068B2/en not_active Ceased
- 1980-09-16 DK DK392580A patent/DK392580A/da not_active Application Discontinuation
- 1980-09-16 PH PH24591A patent/PH15098A/en unknown
- 1980-09-16 ES ES495101A patent/ES8106489A1/es not_active Expired
- 1980-09-16 FI FI802904A patent/FI68615C/fi not_active IP Right Cessation
- 1980-09-16 KR KR1019800003623A patent/KR840000964B1/ko active
- 1980-09-17 AR AR282561A patent/AR225776A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| PT71807B (en) | 1981-07-02 |
| GR70288B (de) | 1982-09-03 |
| IE801927L (en) | 1981-03-17 |
| DE3061160D1 (en) | 1982-12-30 |
| AR225776A1 (es) | 1982-04-30 |
| IE50266B1 (en) | 1986-03-19 |
| KR840000964B1 (ko) | 1984-07-02 |
| FI68615C (fi) | 1985-10-10 |
| IL61038A0 (en) | 1980-11-30 |
| AU6243680A (en) | 1981-03-26 |
| JPS5951938B2 (ja) | 1984-12-17 |
| AU518068B2 (en) | 1981-09-10 |
| PT71807A (en) | 1980-10-01 |
| ES495101A0 (es) | 1981-08-16 |
| PH15098A (en) | 1982-08-10 |
| DK392580A (da) | 1981-03-18 |
| CA1153368A (en) | 1983-09-06 |
| YU236180A (en) | 1983-01-21 |
| KR830003415A (ko) | 1983-06-20 |
| FI802904A (fi) | 1981-03-18 |
| FI68615B (fi) | 1985-06-28 |
| EP0025687B1 (de) | 1982-11-24 |
| US4232173A (en) | 1980-11-04 |
| JPS5651448A (en) | 1981-05-09 |
| ES8106489A1 (es) | 1981-08-16 |
| EP0025687A1 (de) | 1981-03-25 |
| IL61038A (en) | 1983-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3483973D1 (de) | Hydroxypyridone und ihre pharmazeutischen zusammensetzungen. | |
| IT8019049A0 (it) | Composti 2 penem, metodo per laloro preparazione e composizioni farmaceutiche contenenti tali composti. | |
| IT1194900B (it) | N-(fenossialchile)immidazoli,relative composizioni farmaceutiche e procedimento per la loro fabbricazione | |
| DE3586694T2 (de) | 4-substituierte piperazin-2-carbonsaeuren, verfahren und pharmazeutische zusammensetzungen. | |
| IT7826925A0 (it) | Composti eterociclici, procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali composti. | |
| NL990010I1 (nl) | Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten. | |
| IT7927614A0 (it) | 1,2,4,5-tetra-alchil-4-arilpiperidi ne e relative formulazioni farmaceutiche. | |
| IT7830075A0 (it) | Metiladamantil idrazine, loro preparazione e composizioni farmaceutiche che le contengono. | |
| MX9203148A (es) | 2,6-dialcoxipenzamidas y composiciones farmaceuticas que las contienen. | |
| BE865882A (fr) | Derives substitues de prostagandines et compositions pharmaceutiques, comprenant de tels derives | |
| NL187397C (nl) | Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding. | |
| IT8021370A0 (it) | Derivati teofillinmetildiossolanici, procedimenti per la loro preparazione e relative composizioni farmaceutiche. | |
| IT8026672A0 (it) | Derivati peptidici, procedimento per prepararli e relative composizioni farmaceutiche. | |
| IT7927243A0 (it) | Per la loro preparazione e composti triazinonici, procedimenti composizioni farmaceutiche che licontengono. | |
| ATE1858T1 (de) | 15-methanesulfonamidoprostaglandin-derivate, ihre pharmazeutischen zusammensetzungen und verfahren dafuer. | |
| IT7922150A0 (it) | Derivati dell'isochinolina, loro preparazione, e composizioni farmaceutiche che li contengono. | |
| NL7810891A (nl) | Fenoxyalkanolaminederivaten en werkwijze ter bereiding daarvan. | |
| NL7810307A (nl) | 4-fenyl-thieno-/2,3-c/-piperidinen, werkwijze voor het bereiden daarvan alsmede daaruit bereide farmaceutische samenstellingen. | |
| NL187168C (nl) | 3 beta-oxygesubstitueerde-18 beta-olean-30-carboxyderivaten, werkwijze ter bereiding daarvan en farmaceutische preparaten welke een of meer van deze verbindingen bevatten. | |
| NL7806321A (nl) | Piperazinecarbodithiozuurderivaten, werkwijze voor de bereiding daarvan en geneesmiddelen daaruit. | |
| NZ182995A (en) | 5-substituted-indane-2-carboxylic acids,derivatives and pharmaceutical compositions | |
| IT8021956A0 (it) | Derivati dell'isochinolina, loro preparazione e composizioni farmaceutiche che li contengono. | |
| IT7927147A0 (it) | Nuovi derivati penicillanici e cefalosporanici, procedimento per la loro preparazione e relative composizioni farmaceutiche. | |
| NL8403873A (nl) | Pyrazolopyridinederivaten, werkwijzen ter bereiding daarvan alsmede farmaceutische samenstellingen, die deze derivaten bevatten. | |
| MX9203580A (es) | 1,4-dihidropiridinas y composiciones farmaceuticas que las contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |